2009 Buick LaCrosse CX
3.8 L • V6 • FWD • AT
2G4WC582491224096
Sales history: 1
Highlights
Condition
Not provided
Seller
Insurance • State Farm Insurance
Key included
Yes
Docs
Bad
History
1 record
Drive
3.8 L • V6 • FWD • AT
Odometer
Not provided
Primary damage
All over
Loss type
Collision
Docs
OH • BoS Destruction Salvage
Extra
Auction
VIN
2G4WC582491224096
Lot number
42031255
IAAI
Sale status
Sold
Seller type
Insurance
Seller
State Farm Insurance
Location
Lorain, OH
Description
Fuel type
Gasoline
Body color
Silver
Body type
Sedan
Generation
W-body
Trim
CX
All sales final. Always run reports before bid
Sharing our own experience
Over the years, we’ve learned all the ins and outs of car importing — so you don’t have to.
How it works
A full step-by-step guide that walks you through the entire process — from signing up to receiving your car at your doorstep. Clear & beginner-friendly.
Purchase process
Knowledge base
A structured library of content covering every major topic in car importing — including terms, rules, key concepts, and important real-world nuances.
Import encyclopedia
Watch & learn
Short, practical videos packed with tips from real experience. No fluff, no theory — just what actually helps when importing a car from the US to Poland.
Watch guides
Popular Buick models
2009 Buick LaCrosse CX • 3.8 L • V6 • FWD • Automatic • IAAI Lot: 42031255 • VIN: 2G4WC582491224096
Find out more about this 2009 Buick LaCrosse CX, available at the IAAI salvage car auction as lot 42031255 in Lorain, OH. This car has All over main damage. It is listed with Not provided start condition code. Odometer shows Not provided. This Silver Buick LaCrosse Sedan is equipped with Gasoline 3.8 L engine, FWD drivetrain, Automatic transmission. Check the vehicle history report for 2G4WC582491224096 to access detailed information on accidents, ownership, and title status. Review pricing trends and uncover hidden issues before placing your bid.
We use cookies to improve your experience and analyze site usage, as outlined in our Privacy policy. By closing this message or continuing to browse, you consent to their use.
